Acurx Pharmaceuticals, Inc. ( ACXP) - Stock Earnings
ACXP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 14, 2026, midnight | — / — | — | — / — | — |
ACXP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.6 million USD | — USD |
| 2026Q1 | -1.7 million USD | — USD |
| 2026Q2 | -2.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ACXP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.6 million USD | — USD |
| 2024 | -14.1 million USD | — USD |
| 2025 | -8.0 million USD | — USD |
| 2026 Est. | — | — |
ACXP
Price: $1.44
52 week price:
Earnings Per Share: -3.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 73400
Market Capitalization: 6.0 million